into account the real dose administered to children with spasticity associated with dynamic
equinus foot deformity due to cerebral palsy. Method A single centre, observational,
longitudinal, and retrospective study which included spastic paediatric patients aged 2-to-18-
years and treated with onabotulinumtoxinA or abobotulinumtoxinA from December 1995 to
October 2012, in the Paediatric Neurology Unit of a first-level Spanish hospital. A …